Drugs / AZD0305
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06106945 | Dec 2023 → Aug 2027 expected | plasma cell myeloma | AstraZeneca | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AZD0305 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06106945 ↗ |